tiprankstipranks
Icon plc (ICLR)
NASDAQ:ICLR
US Market
ICLR
Icon
RESEARCH TOOLSreports
Want to see ICLR full AI Analyst Report?

Icon (ICLR) Stock Forecast & Price Target

559 Followers
See the Price Targets and Ratings of:

ICLR Analyst Ratings

Moderate Buy
15Ratings
Moderate Buy
10 Buy
4 Hold
1 Sell
Based on 15 analysts giving stock ratings to
Icon
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ICLR Stock 12 Month Forecast

Average Price Target

$183.79
▲(10.87% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Icon in the last 3 months. The average price target is $183.79 with a high forecast of $220.00 and a low forecast of $145.00. The average price target represents a 10.87% change from the last price of $165.76.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"107":"$107","164":"$164","221":"$221","135.5":"$135.5","192.5":"$192.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":220,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$220.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":183.78571428571428,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$183.79</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":145,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$145.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[107,135.5,164,192.5,221],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,163.565,167.90615384615384,172.2473076923077,176.58846153846153,180.92961538461537,185.27076923076922,189.61192307692306,193.95307692307694,198.29423076923075,202.63538461538462,206.97653846153844,211.3176923076923,215.65884615384616,{"y":220,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,163.565,165.12043956043956,166.67587912087913,168.23131868131867,169.78675824175824,171.3421978021978,172.89763736263737,174.4530769230769,176.00851648351647,177.56395604395604,179.1193956043956,180.67483516483514,182.2302747252747,{"y":183.78571428571428,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,163.565,162.13692307692307,160.70884615384614,159.28076923076924,157.8526923076923,156.42461538461538,154.99653846153845,153.56846153846155,152.14038461538462,150.7123076923077,149.28423076923076,147.85615384615386,146.42807692307693,{"y":145,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":166.44,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.84,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":192.31,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":171.82,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":179.71,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":182.22,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.59,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.27,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":111.42,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.85,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":138.03,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":175.05,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.565,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$220.00Average Price Target$183.79Lowest Price Target$145.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on ICLR
Casey Woodring
J.P. Morgan
J.P. Morgan
$155→$165
Hold
-0.46%
Downside
Reiterated
08/04/26
J.P. Morgan Reaffirms Their Hold Rating on Icon (ICLR)
TD Cowen Analyst forecast on ICLR
Charles Rhyee
TD Cowen
TD Cowen
$197
Buy
18.85%
Upside
Assigned
08/03/26
Analysts Offer Insights on Healthcare Companies: Icon (NASDAQ: ICLR) and IDEAYA Biosciences (NASDAQ: IDYA)
Robert W. Baird Analyst forecast on ICLR
Eric Coldwell
Robert W. Baird
Robert W. Baird
$192→$194
Buy
17.04%
Upside
Reiterated
07/31/26
Icon price target raised to $194 from $192 at BairdIcon price target raised to $194 from $192 at Baird
Truist Financial Analyst forecast on ICLR
Jailendra Singh
Truist Financial
Truist Financial
$207→$209
Buy
26.09%
Upside
Reiterated
07/31/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD) and Icon (NASDAQ: ICLR)
Bank of America Securities Analyst forecast on ICLR
Michael Ryskin
Bank of America Securities
Bank of America Securities
$150→$160
Sell
-3.47%
Downside
Reiterated
07/30/26
Icon Plc: Sell Rating Reiterated as Margin Upside Limited and Shares Trade Above Raised $160 Price Target
Evercore ISI Analyst forecast on ICLR
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$220
Buy
32.72%
Upside
Reiterated
07/30/26
Evercore ISI Keeps Their Buy Rating on Icon (ICLR)
RBC Capital Analyst forecast on ICLR
Ryan Halsted
RBC Capital
RBC Capital
$185
Buy
11.61%
Upside
Reiterated
07/30/26
RBC Capital Sticks to Their Buy Rating for Icon (ICLR)
William Blair Analyst forecast on ICLR
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
07/29/26
Analysts' Top Healthcare Picks: Icon (ICLR), Biogen (BIIB)
Mizuho Securities Analyst forecast on ICLR
Ann Hynes
Mizuho Securities
Mizuho Securities
$180→$190
Buy
14.62%
Upside
Reiterated
06/26/26
Icon price target raised to $190 from $180 at MizuhoIcon price target raised to $190 from $180 at Mizuho
Jefferies Analyst forecast on ICLR
David Windley
Jefferies
Jefferies
$135→$193
Buy
16.43%
Upside
Reiterated
06/25/26
Jefferies Reaffirms Their Buy Rating on Icon (ICLR)
Citi Analyst forecast on ICLR
Patrick B Donnelly
Citi
Citi
$140→$165
Hold
-0.46%
Downside
Assigned
06/25/26
Icon price target raised to $165 from $140 at CitiIcon price target raised to $165 from $140 at Citi
Deutsche Bank Analyst forecast on ICLR
Justin Bowers
Deutsche Bank
Deutsche Bank
$180→$188
Buy
13.42%
Upside
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Icon (NASDAQ: ICLR)
BMO Capital Analyst forecast on ICLR
Sean Dodge
BMO Capital
BMO Capital
$160→$187
Buy
12.81%
Upside
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (NASDAQ: SPRY), Gilead Sciences (NASDAQ: GILD) and Icon (NASDAQ: ICLR)
Barclays Analyst forecast on ICLR
Luke Sergott
Barclays
Barclays
$150→$175
Hold
5.57%
Upside
Reiterated
06/24/26
Barclays Remains a Hold on Icon (ICLR)
Leerink Partners Analyst forecast on ICLR
Michael Cherny
Leerink Partners
Leerink Partners
$125→$145
Hold
-12.52%
Downside
Reiterated
05/28/26
Icon price target raised to $145 from $125 at LeerinkIcon price target raised to $145 from $125 at Leerink
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on ICLR
Casey Woodring
J.P. Morgan
J.P. Morgan
$155→$165
Hold
-0.46%
Downside
Reiterated
08/04/26
J.P. Morgan Reaffirms Their Hold Rating on Icon (ICLR)
TD Cowen Analyst forecast on ICLR
Charles Rhyee
TD Cowen
TD Cowen
$197
Buy
18.85%
Upside
Assigned
08/03/26
Analysts Offer Insights on Healthcare Companies: Icon (NASDAQ: ICLR) and IDEAYA Biosciences (NASDAQ: IDYA)
Robert W. Baird Analyst forecast on ICLR
Eric Coldwell
Robert W. Baird
Robert W. Baird
$192→$194
Buy
17.04%
Upside
Reiterated
07/31/26
Icon price target raised to $194 from $192 at BairdIcon price target raised to $194 from $192 at Baird
Truist Financial Analyst forecast on ICLR
Jailendra Singh
Truist Financial
Truist Financial
$207→$209
Buy
26.09%
Upside
Reiterated
07/31/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD) and Icon (NASDAQ: ICLR)
Bank of America Securities Analyst forecast on ICLR
Michael Ryskin
Bank of America Securities
Bank of America Securities
$150→$160
Sell
-3.47%
Downside
Reiterated
07/30/26
Icon Plc: Sell Rating Reiterated as Margin Upside Limited and Shares Trade Above Raised $160 Price Target
Evercore ISI Analyst forecast on ICLR
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$220
Buy
32.72%
Upside
Reiterated
07/30/26
Evercore ISI Keeps Their Buy Rating on Icon (ICLR)
RBC Capital Analyst forecast on ICLR
Ryan Halsted
RBC Capital
RBC Capital
$185
Buy
11.61%
Upside
Reiterated
07/30/26
RBC Capital Sticks to Their Buy Rating for Icon (ICLR)
William Blair Analyst forecast on ICLR
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
07/29/26
Analysts' Top Healthcare Picks: Icon (ICLR), Biogen (BIIB)
Mizuho Securities Analyst forecast on ICLR
Ann Hynes
Mizuho Securities
Mizuho Securities
$180→$190
Buy
14.62%
Upside
Reiterated
06/26/26
Icon price target raised to $190 from $180 at MizuhoIcon price target raised to $190 from $180 at Mizuho
Jefferies Analyst forecast on ICLR
David Windley
Jefferies
Jefferies
$135→$193
Buy
16.43%
Upside
Reiterated
06/25/26
Jefferies Reaffirms Their Buy Rating on Icon (ICLR)
Citi Analyst forecast on ICLR
Patrick B Donnelly
Citi
Citi
$140→$165
Hold
-0.46%
Downside
Assigned
06/25/26
Icon price target raised to $165 from $140 at CitiIcon price target raised to $165 from $140 at Citi
Deutsche Bank Analyst forecast on ICLR
Justin Bowers
Deutsche Bank
Deutsche Bank
$180→$188
Buy
13.42%
Upside
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Icon (NASDAQ: ICLR)
BMO Capital Analyst forecast on ICLR
Sean Dodge
BMO Capital
BMO Capital
$160→$187
Buy
12.81%
Upside
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (NASDAQ: SPRY), Gilead Sciences (NASDAQ: GILD) and Icon (NASDAQ: ICLR)
Barclays Analyst forecast on ICLR
Luke Sergott
Barclays
Barclays
$150→$175
Hold
5.57%
Upside
Reiterated
06/24/26
Barclays Remains a Hold on Icon (ICLR)
Leerink Partners Analyst forecast on ICLR
Michael Cherny
Leerink Partners
Leerink Partners
$125→$145
Hold
-12.52%
Downside
Reiterated
05/28/26
Icon price target raised to $145 from $125 at LeerinkIcon price target raised to $145 from $125 at Leerink
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Icon

3 Months
David WindleyJefferies
Success Rate
27/43 ratings generated profit
63%
Average Return
+2.93%
Copying David Windley's trades and holding each position for 3 Months would result in 62.79% of your transactions generating a profit, with an average return of +2.93% per trade.
1 Year
David WindleyJefferies
Success Rate
26/43 ratings generated profit
60%
Average Return
+3.88%
Copying David Windley's trades and holding each position for 1 Year would result in 60.47% of your transactions generating a profit, with an average return of +3.88% per trade.
2 Years
David WindleyJefferies
Success Rate
26/43 ratings generated profit
60%
Average Return
+10.17%
Copying David Windley's trades and holding each position for 2 Years would result in 60.47% of your transactions generating a profit, with an average return of +10.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ICLR Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
1
1
1
0
0
Buy
6
8
16
21
16
Hold
9
13
15
14
6
Sell
1
1
3
4
3
Strong Sell
0
0
0
0
0
total
17
23
35
39
25
In the current month, ICLR has received 16 Buy Ratings, 6 Hold Ratings, and 3 Sell Ratings. ICLR average Analyst price target in the past 3 months is 183.79.
Each month's total comprises the sum of three months' worth of ratings.

ICLR Financial Forecast

ICLR Earnings Forecast

Next quarter’s earnings estimate for ICLR is $2.68 with a range of $2.61 to $2.75. The previous quarter’s EPS was $2.56. ICLR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year ICLR has Performed in-line its overall industry.
Next quarter’s earnings estimate for ICLR is $2.68 with a range of $2.61 to $2.75. The previous quarter’s EPS was $2.56. ICLR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year ICLR has Performed in-line its overall industry.

ICLR Sales Forecast

Next quarter’s sales forecast for ICLR is $2.01B with a range of $1.96B to $2.03B. The previous quarter’s sales results were $2.06B. ICLR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year ICLR has Performed in-line its overall industry.
Next quarter’s sales forecast for ICLR is $2.01B with a range of $1.96B to $2.03B. The previous quarter’s sales results were $2.06B. ICLR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year ICLR has Performed in-line its overall industry.

ICLR Stock Forecast FAQ

What is ICLR’s average 12-month price target, according to analysts?
Based on analyst ratings, Icon plc’s 12-month average price target is 183.79.
    What is ICLR’s upside potential, based on the analysts’ average price target?
    Icon plc has 10.87% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ICLR a Buy, Sell or Hold?
          Icon plc has a consensus rating of Moderate Buy which is based on 10 buy ratings, 4 hold ratings and 1 sell ratings.
            What is Icon plc’s price target?
            The average price target for Icon plc is 183.79. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $220.00 ,the lowest forecast is $145.00. The average price target represents 10.87% Increase from the current price of $165.76.
              What do analysts say about Icon plc?
              Icon plc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of ICLR?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.